21.57
Schlusskurs vom Vortag:
$21.26
Offen:
$21.21
24-Stunden-Volumen:
412.50K
Relative Volume:
0.47
Marktkapitalisierung:
$1.77B
Einnahmen:
$1.93B
Nettoeinkommen (Verlust:
$174.22M
KGV:
10.52
EPS:
2.0516
Netto-Cashflow:
$237.32M
1W Leistung:
-6.33%
1M Leistung:
-6.46%
6M Leistung:
-11.85%
1J Leistung:
+58.94%
Pediatrix Medical Group Inc Stock (MD) Company Profile
Firmenname
Pediatrix Medical Group Inc
Sektor
Branche
Telefon
(954) 384-0175
Adresse
1301 CONCORD TERRACE, SUNRISE, FL
Compare MD vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group Inc
|
21.57 | 1.75B | 1.93B | 174.22M | 237.32M | 2.0516 |
|
HCA
Hca Healthcare Inc
|
393.74 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
|
THC
Tenet Healthcare Corp
|
178.80 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
|
DVA
Davita Inc
|
196.08 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
|
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
|
EHC
Encompass Health Corp
|
105.42 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Pediatrix Medical Group Inc Stock (MD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-09-26 | Hochstufung | Jefferies | Hold → Buy |
| 2024-06-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2021-09-27 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-10-19 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2020-01-03 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-12-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-09-06 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-01-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Hold |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-09-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-09-18 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2018-08-03 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-07-12 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2018-03-27 | Eingeleitet | Credit Suisse | Neutral |
| 2018-02-12 | Bestätigt | Mizuho | Neutral |
| 2017-12-13 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-09-18 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2017-05-30 | Bestätigt | Mizuho | Neutral |
| 2017-05-25 | Bestätigt | Stifel | Hold |
| 2017-05-04 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-03-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2017-03-10 | Herabstufung | JP Morgan | Overweight → Neutral |
Alle ansehen
Pediatrix Medical Group Inc Aktie (MD) Neueste Nachrichten
Pediatrix Medical Group Inc (NYSE:MD) Offers a Compelling Value Proposition with Strong Fundamentals - ChartMill
A Look at Pediatrix Medical Group Inc (MD) After 4.1% Decline -- GF Value $13.12 vs Price $21.55 - GuruFocus
Here's why Pediatrix Medical Group (MD) is a strong growth stock - MSN
A Look At Pediatrix Medical Group (MD) Valuation After Q1 Update And Raised Analyst Outlook - Sahm
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock - Yahoo Finance
How Investors Are Reacting To Pediatrix Medical Group (MD) Pricing‑Driven Earnings Outperformance And Margin Gains - Yahoo Finance
MD SEC FilingsPediatrix Medical Group, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Why Pediatrix Medical Group (MD) is a top momentum stock for the long term - MSN
Pediatrix Medical Group (MD) Q1 Earnings and Revenues Surpass Estimates - Eastern Progress
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now - Zacks Investment Research
The 5 Most Interesting Analyst Questions From Pediatrix Medical Group’s Q1 Earnings Call - Yahoo Finance
Weis family trust tied to Pediatrix (MD) director sells 36,028 shares - Stock Titan
Pediatrix (NYSE: MD) director McEachin reports 22,854-share stock gift - Stock Titan
Mizuho Lifts PT on Pediatrix Medical Group (MD) Following Q1 Results - Insider Monkey
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Pediatrix Medical Group (MD) Is Up 13.7% After Beating EPS and Reaffirming EBITDA OutlookHas The Bull Case Changed? - Sahm
How Pediatrix Medical Group Inc. (MD) Affects Rotational Strategy Timing - Stock Traders Daily
Pediatrix Medical Group (NYSE: MD) files Form 144 to resell 36,028 shares - Stock Titan
[Form 4] Pediatrix Medical Group, Inc. Insider Trading Activity - Stock Titan
Pediatrix. (MD) Reports Q1 EPS Beat - Insider Monkey
UBS Maintains Pediatrix Medical Group (MD) Neutral Recommendation - MSN
5 Best Small Cap US Stocks to Buy - Insider Monkey
15 Best Small Cap Stocks to Buy for 10x Potential - Insider Monkey
UBS Adjusts Price Target on Pediatrix Medical to $25 From $22, Maintains Neutral Rating - marketscreener.com
Pediatrix Medical Group (MD) director receives 7,196-share restricted stock award - Stock Titan
Pediatrix (MD) director Linynsky receives 7,196-share restricted stock award - Stock Titan
Pediatrix (NYSE: MD) director receives 7,196 restricted shares in equity award - Stock Titan
Pediatrix (NYSE: MD) director awarded 7,196 restricted shares - Stock Titan
Pediatrix (MD) director receives 7,196 restricted shares in annual equity award - Stock Titan
Director Shirley Weis receives 7,196 Pediatrix (MD) restricted shares award - Stock Titan
Pediatrix (NYSE: MD) director gets 7,196 restricted shares in equity grant - Stock Titan
Pediatrix (MD) director awarded 7,196 restricted shares in annual equity grant - Stock Titan
Pediatrix Medical Group Q1 Earnings Call Highlights - MarketBeat
Earnings call transcript: Pediatrix Medical Group beats Q1 2026 expectations - Investing.com
Earnings call transcript: Pediatrix Medical Group beats Q1 2026 expectations By Investing.com - Investing.com Nigeria
TradingKey - TradingKey
Vanguard Group Inc. Sells 168,618 Shares of Pediatrix Medical Group, Inc. $MD - MarketBeat
A Look At Pediatrix Medical Group (MD) Valuation After Its Strong First Quarter Earnings Update - Sahm
MD: Pediatrix Medical Group, Inc.Interactive Chart - Zacks Investment Research
Pediatrix Medical Group, Inc. Just Recorded A 10% EPS Beat: Here's What Analysts Are Forecasting Next - Yahoo Finance
Pediatrix Medical Group (MD) adds 8M shares to incentive plan at 2026 meeting - Stock Titan
Pediatrix Medical Group Q4 Profitability Turnaround Tests Market Skepticism On Slow Growth - Sahm
Pediatrix Medical Group Stock Hits Day Low Amid Price Pressure at $19.65 - Markets Mojo
Transcript: Pediatrix Medical Group Q1 2026 Earnings Conference Call - Sahm
Should Stronger Same‑Unit Revenue And Reaffirmed Outlook Require Action From Pediatrix Medical Group (MD) Investors? - Sahm
Pediatrix Medical Group Q1 2026 earnings preview - MSN
Pediatrix Medical Group, Inc. (NYSE:MD) Q1 2026 Earnings Call Transcript - Insider Monkey
Pediatrix Medical Group Reaffirms EBITDA Outlook on Call - TipRanks
Pediatrix Medical Q1 Earnings Beat Estimates on Same-Unit Strength - sharewise.com
Pediatrix Medical Group (MD) Q1 earnings and revenues surpass estimates - MSN
Pediatrix Medical Group, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Finanzdaten der Pediatrix Medical Group Inc-Aktie (MD)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):